Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10,358Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Octavius Pharma Pvt. Ltd

02 2ACS DOBFAR SPA

03 6ANI Pharmaceuticals Inc

04 1American Regent

05 1Amneal Pharmaceuticals

06 2Anwita Drugs

07 1Aurobindo Pharma Limited

08 2Bionpharma

09 10CHIESI USA INC

10 2Cipla

11 1Cooper Pharma Limited

12 1Deva Holding AS

13 2Epic Pharma. LLC.

14 4Farbe Firma

15 2Glenmark Pharmaceuticals

16 1Ha Noi CPC1 Pharmaceutical JSC

17 4Hikma Pharmaceuticals

18 1Loxim Industries

19 1Micro Labs Limited

20 1Murli Krishna Pharma

21 2NORVIUM BIOSCIENCE

22 1Navinta

23 1RK Pharma

24 2ROTTAPHARM SpA

25 2SKG-Pharma

26 2Senores Pharmaceuticals

27 1Sichuan Qingmu Pharmaceutical

28 1Sun Pharmaceutical Industries Limited

29 1Viatris

30 1Wockhardt

31 1Zhejiang Xianju Pharmaceutical Co. Ltd

32 2Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Regulatory Info :

Registration Country : India

Nicardipine Hydrochloride

Brand Name : Nicardipine

Dosage Form : Pellets for Capsules

Dosage Strength : 22%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

02

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 25MG/10ML (2.5MG/ML)

Packaging :

Approval Date : 2009-11-17

Application Number : 90534

Regulatory Info : RX

Registration Country : USA

blank

03

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 20MG

Packaging :

Approval Date : 1996-12-10

Application Number : 74439

Regulatory Info : DISCN

Registration Country : USA

blank

04

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 1996-12-10

Application Number : 74439

Regulatory Info : DISCN

Registration Country : USA

blank

05

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 20MG

Packaging :

Approval Date : 1996-10-28

Application Number : 74540

Regulatory Info : DISCN

Registration Country : USA

blank

06

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 1996-10-28

Application Number : 74540

Regulatory Info : DISCN

Registration Country : USA

blank

07

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 20MG

Packaging :

Approval Date : 1996-10-28

Application Number : 74670

Regulatory Info : RX

Registration Country : USA

blank

08

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 1996-10-28

Application Number : 74670

Regulatory Info : RX

Registration Country : USA

blank

09

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : CARDENE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1988-12-21

Application Number : 19488

Regulatory Info : DISCN

Registration Country : USA

blank

10

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : CARDENE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1988-12-21

Application Number : 19488

Regulatory Info : DISCN

Registration Country : USA

blank

11

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : CARDENE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1992-01-30

Application Number : 19734

Regulatory Info : DISCN

Registration Country : USA

blank

12

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 20MG/200ML (0.1MG/ML)

Packaging :

Approval Date : 2008-07-31

Application Number : 19734

Regulatory Info : RX

Registration Country : USA

blank

13

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 20MG/200ML (0.1MG/ML)

Packaging :

Approval Date : 2008-07-31

Application Number : 19734

Regulatory Info : RX

Registration Country : USA

blank

14

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 40MG/200ML (0.2MG/ML)

Packaging :

Approval Date : 2008-11-07

Application Number : 19734

Regulatory Info : RX

Registration Country : USA

blank

15

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 40MG/200ML (0.2MG/ML)

Packaging :

Approval Date : 2008-11-07

Application Number : 19734

Regulatory Info : DISCN

Registration Country : USA

blank

16

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : CARDENE SR

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1992-02-21

Application Number : 20005

Regulatory Info : DISCN

Registration Country : USA

blank

17

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : CARDENE SR

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1992-02-21

Application Number : 20005

Regulatory Info : DISCN

Registration Country : USA

blank

18

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : CARDENE SR

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1992-02-21

Application Number : 20005

Regulatory Info : DISCN

Registration Country : USA

blank

19

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 20MG

Packaging :

Approval Date : 1998-03-19

Application Number : 74928

Regulatory Info : RX

Registration Country : USA

blank

20

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 1998-03-19

Application Number : 74928

Regulatory Info : RX

Registration Country : USA

blank

21

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 25MG/10ML (2.5MG/ML)

Packaging :

Approval Date : 2008-07-24

Application Number : 22276

Regulatory Info : RX

Registration Country : USA

blank

22

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 20MG/200ML (0.1MG/ML)

Packaging :

Approval Date : 2016-04-07

Application Number : 22276

Regulatory Info : RX

Registration Country : USA

blank

23

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 40MG/200ML (0.2MG/ML)

Packaging :

Approval Date : 2016-04-07

Application Number : 22276

Regulatory Info : RX

Registration Country : USA

blank

24

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 25MG/10ML (2.5MG/ML)

Packaging :

Approval Date : 2009-12-28

Application Number : 78714

Regulatory Info : DISCN

Registration Country : USA

blank

25

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 25MG/10ML (2.5MG/ML)

Packaging :

Approval Date : 2009-11-17

Application Number : 90125

Regulatory Info : DISCN

Registration Country : USA

blank

26

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 25MG/10ML (2.5MG/ML)

Packaging :

Approval Date : 2009-11-17

Application Number : 90664

Regulatory Info : RX

Registration Country : USA

blank

27

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 25MG/10ML (2.5MG/ML)

Packaging :

Approval Date : 2009-11-17

Application Number : 78405

Regulatory Info : DISCN

Registration Country : USA

blank

28

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 25MG/10ML (2.5MG/ML)

Packaging :

Approval Date : 2009-11-17

Application Number : 90671

Regulatory Info : RX

Registration Country : USA

blank

29

NORVIUM BIOSCIENCE

Country
Cancer Research
Not Confirmed
arrow

NORVIUM BIOSCIENCE

Country
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 20MG

Packaging :

Approval Date : 1996-07-18

Application Number : 74642

Regulatory Info : DISCN

Registration Country : USA

blank

30

NORVIUM BIOSCIENCE

Country
Cancer Research
Not Confirmed
arrow

NORVIUM BIOSCIENCE

Country
arrow
Cancer Research
Not Confirmed

NICARDIPINE HYDROCHLORIDE

Brand Name : NICARDIPINE HYDROCHLORIDE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 1996-07-18

Application Number : 74642

Regulatory Info : DISCN

Registration Country : USA

blank